Anastrozole

Chemical formula: C₁₇H₁₉N₅  Molecular mass: 293.366 g/mol  PubChem compound: 2187

Therapeutic indications

Anastrozole is indicated for:

Hormone receptor-positive breast cancer in postmenopausal women

Population group: women, only adults (18 years old or older)

Anastrozole is indicated for the:

  • Treatment of hormone receptor-positive advanced breast cancer in postmenopausal women.
  • Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women.
  • Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Anastrozole is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: ARIMIDEX Film-coated tablets
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈